Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05007925 · ClinicalTrials.gov registry record · NA
Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
A NA study of Peripheral Artery Disease, sponsored by Shockwave Medical.
- Active
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT05007925 is a NA study of Peripheral Artery Disease that is active but no longer recruiting, run by Shockwave Medical. The registered enrollment target is 250 participants, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (105% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT05007925, a NA study of Peripheral Artery Disease, is active but no longer recruiting, sponsored by Shockwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
To assess the continued safety, effectiveness, and optimal clinical use of the Shockwave Medical Peripheral IVL System for the treatment of calcified, stenotic BTK arteries. Post-market, prospective , multi-center, single-arm study.
Conditions Studied
Interventions
- DEVICE Intravascular Lithotripsy
Study Locations (20)
California
- UCSF Fresno - Fresno
- Scripps Memorial Hospital - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- Stanford Hospital - Palo Alto
- UC Davis Health - Sacramento
- St. Helena Hospital - St. Helena
Massachusetts
- Massachusetts General Hospital - Boston
- Southcoast Hospitals Group - New Bedford
Michigan
- McLaren Bay Heart and Vascular - Bay City
- McLaren Greater Lansing - Lansing
Missouri
- St. Luke's Hospital - Kansas City
- Barnes-Jewish Hospital - St Louis
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Florida
- Tallahassee Memorial Hospital - Tallahassee
Georgia
- Piedmont Heart Institute - Atlanta
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-11-18 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05007925
The ClinicalTrials.gov registry entry for NCT05007925 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 122-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (105% higher). The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Intravascular Lithotripsy is the first listed.
NCT05007925 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT05007925 about?
NCT05007925 is a clinical study titled "Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System". To assess the continued safety, effectiveness, and optimal clinical use of the Shockwave Medical Peripheral IVL System for the treatment of calcified, stenotic BTK arteries. Post-market, prospective , multi-center, single-arm study.
What is the current status of trial NCT05007925?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-11-18. Estimated completion is 2026-04-01.
What conditions does trial NCT05007925 study?
This clinical trial studies the following conditions: Peripheral Artery Disease.
What interventions are being tested in trial NCT05007925?
The interventions under investigation include: Intravascular Lithotripsy (DEVICE).
Who is sponsoring clinical trial NCT05007925?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05007925 being conducted?
This trial has 20 study locations across California, District of Columbia, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.